Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Curis Inc (NQ: CRIS ) 6.490 -0.180 (-2.70%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Curis Inc < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Monday's After-Market Session December 12, 2022 Via Benzinga Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session December 12, 2022 Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. Via Benzinga Earnings Outlook For Curis November 08, 2022 Curis (NASDAQ:CRIS) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Curis will report an... Via Benzinga Why Is Curis (CRIS) Stock Up 20% Today? August 18, 2022 Curis just received a regulatory nod for its lymphoma treatment study from the FDA. Now CRIS stock traders are buying today. Via InvestorPlace FDA Clears Curis' Lymphoma Study, Keeping Leukemia Trial Still Stalled August 18, 2022 Via Benzinga Curis Shares Gain On Encouraging Data Presentation From Blood Cancer Trials At ASCO Meeting June 06, 2022 Via Benzinga Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket September 26, 2022 Gainers Via Benzinga Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary August 30, 2022 Via Benzinga Curis Resumes Enrollment In Monotherapy TakeAim Leukemia Study, Combo Phase Still Under Partial Hold August 30, 2022 The FDA has notified Curis Inc (NASDAQ: CRIS) to resume enrollment of additional patients in the monotherapy phase of the TakeAim Leukemia study of Emavusertib. Via Benzinga Curis's Return On Capital Employed Insights August 24, 2022 According to Benzinga Pro data, during Q2, Curis (NASDAQ:CRIS) posted sales of $2.39 million. Earnings were up 1.05%, but Curis still reported an overall loss of $15.94 million. Via Benzinga After Leukemia Trial, FDA Puts Partial Hold On Curis' Lymphoma Study April 11, 2022 Via Benzinga This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday August 19, 2022 Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. Via Benzinga Recap Of Thursday's Biotech Catalysts - End Of the Day Summary August 18, 2022 Via Benzinga Analyzing Curis Short Interest August 18, 2022 Curis (NASDAQ:CRIS) short percent of float has fallen 4.29% since its last report. The company recently reported that it has 3.58 million shares sold short, which is... Via Benzinga Dow Falls 60 Points; Crude Oil Rises Sharply August 18, 2022 U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 60 points on Thursday. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session August 18, 2022 Via Benzinga BLUE Stock Moves as FDA Approves Bluebird Bio’s Gene Therapy August 18, 2022 Bluebird Bio (BLUE) stock is on the move Thursday following FDA approval for beta-thalassemia treatment ZYNTEGLO in adults and children. Via InvestorPlace U.S. Stocks Turn Higher; Nasdaq Rises 50 Points August 18, 2022 U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 50 points on Thursday. Via Benzinga Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session August 18, 2022 Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session August 18, 2022 Via Benzinga 6 Penny Stocks With 1,000% Upside Potential July 24, 2022 Each of these penny stocks with 1,000% upside potential could rise 10X in the future for investors with a high risk tolerance. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session June 06, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 06, 2022 Welcome back and get ready for another week of trading as we start it with the biggest pre-market stock movers for Monday! Via InvestorPlace 12 Health Care Stocks Moving In Friday's Intraday Session June 03, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 31, 2022 On Tuesday, 36 companies achieved new lows for the year. Via Benzinga 20 Stocks Moving in Friday's Pre-Market Session May 20, 2022 Gainers Exicure, Inc. (NASDAQ: XCUR) shares rose 28.1% to $0.1550 in pre-market trading. Exicure said in Form4 filing a director bought 1,472,126 shares at average price of $0.19 per share. Via Benzinga Earnings Outlook For Curis May 04, 2022 Curis (NASDAQ:CRIS) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Curis will report an... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 02, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2022 April 05, 2022 Upgrades Via Benzinga 68 Biggest Movers From Yesterday April 05, 2022 Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.